Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

New factors that affect quality of life in patients with aphasia.

Bullier B, Cassoudesalle H, Villain M, Cogné M, Mollo C, De Gabory I, Dehail P, Joseph PA, Sibon I, Glize B.

Ann Phys Rehabil Med. 2019 Jul 25. pii: S1877-0657(19)30106-X. doi: 10.1016/j.rehab.2019.06.015. [Epub ahead of print]

PMID:
31352062
2.

Angioedema associated with thrombolysis for ischemic stroke: analysis of a case-control study.

Vigneron C, Lécluse A, Ronzière T, Bouillet L, Boccon-Gibod I, Gayet S, Doche E, Smadja D, Di Legge S, Dumont F, Gaudron M, Ion I, Marcel S, Sévin M, Vlaicu MB, Launay D, Arnaud I, Girard-Madoux P, Héroum C, Lefèvre S, Marc G, Obadia M, Sablot D, Sibon I, Suissa L, Gobert D, Detante O, Alamowitch S, Fain O, Javaud N.

J Intern Med. 2019 Jul 18. doi: 10.1111/joim.12962. [Epub ahead of print]

PMID:
31319000
3.

Chronic Cortical Cerebral Microinfarcts Slow Down Cognitive Recovery After Acute Ischemic Stroke.

Sagnier S, Okubo G, Catheline G, Munsch F, Bigourdan A, Debruxelles S, Poli M, Olindo S, Renou P, Rouanet F, Dousset V, Tourdias T, Sibon I.

Stroke. 2019 Jun;50(6):1430-1436. doi: 10.1161/STROKEAHA.118.024672. Epub 2019 May 14.

PMID:
31084336
4.

Asymptomatic stroke is an underestimated side effect of cabozantinib.

Bronnimann C, Sibon I, Ravaud A, Gross-Goupil M.

Rev Neurol (Paris). 2019 Jun;175(6):409-410. doi: 10.1016/j.neurol.2018.10.008. Epub 2019 May 2. No abstract available.

PMID:
31056194
5.

Neurodegeneration of the Substantia Nigra after Ipsilateral Infarct: MRI R2* Mapping and Relationship to Clinical Outcome.

Linck PA, Kuchcinski G, Munsch F, Griffier R, Lopes R, Okubo G, Sagnier S, Renou P, Asselineau J, Perez P, Dousset V, Sibon I, Tourdias T.

Radiology. 2019 May;291(2):438-448. doi: 10.1148/radiol.2019182126. Epub 2019 Mar 12.

PMID:
30860451
6.

Glucose Modifies the Effect of Endovascular Thrombectomy in Patients With Acute Stroke.

Chamorro Á, Brown S, Amaro S, Hill MD, Muir KW, Dippel DWJ, van Zwam W, Butcher K, Ford GA, den Hertog HM, Mitchell PJ, Demchuk AM, Majoie CBLM, Bracard S, Sibon I, Jadhav AP, Lara-Rodriguez B, van der Lugt A, Osei E, Renú A, Richard S, Rodriguez-Luna D, Donnan GA, Dixit A, Almekhlafi M, Deltour S, Epstein J, Guillon B, Bakchine S, Gomis M, du Mesnil de Rochemont R, Lopes D, Reddy V, Rudel G, Roos YBWEM, Bonafe A, Diener HC, Berkhemer OA, Cloud GC, Davis SM, van Oostenbrugge R, Guillemin F, Goyal M, Campbell BCV, Menon BK; HERMES Collaborators.

Stroke. 2019 Mar;50(3):690-696. doi: 10.1161/STROKEAHA.118.023769.

PMID:
30777000
7.

The Influence of Stroke Location on Cognitive and Mood Impairment. A Voxel-Based Lesion-Symptom Mapping Study.

Sagnier S, Munsch F, Bigourdan A, Debruxelles S, Poli M, Renou P, Olindo S, Rouanet F, Dousset V, Tourdias T, Sibon I.

J Stroke Cerebrovasc Dis. 2019 May;28(5):1236-1242. doi: 10.1016/j.jstrokecerebrovasdis.2019.01.010. Epub 2019 Feb 2.

PMID:
30718064
8.

Transcranial direct current stimulation in post-stroke aphasia rehabilitation: A systematic review.

Biou E, Cassoudesalle H, Cogné M, Sibon I, De Gabory I, Dehail P, Aupy J, Glize B.

Ann Phys Rehabil Med. 2019 Mar;62(2):104-121. doi: 10.1016/j.rehab.2019.01.003. Epub 2019 Jan 17.

PMID:
30660671
9.

Cost-effectiveness analysis of mechanical thrombectomy plus tissue-type plasminogen activator compared with tissue-type plasminogen activator alone for acute ischemic stroke in France.

Kaboré N, Marnat G, Rouanet F, Barreau X, Verpillot E, Menegon P, Maachi I, Berge J, Sibon I, Bénard A.

Rev Neurol (Paris). 2019 Apr;175(4):252-260. doi: 10.1016/j.neurol.2018.06.007. Epub 2019 Jan 11.

PMID:
30642680
10.

Post-stroke follow-up: Time to organize.

Santos E, Broussy S, Lesaine E, Saillour F, Rouanet F, Dehail P, Joseph PA, Aly F, Sibon I, Glize B.

Rev Neurol (Paris). 2019 Jan - Feb;175(1-2):59-64. doi: 10.1016/j.neurol.2018.02.087. Epub 2018 Oct 4.

PMID:
30293879
11.

Immune-Thrombotic Thrombocytopenic Purpura is a Rare Cause of Ischemic Stroke in Young Adults: Case Reports and Literature Review.

Tomich C, Debruxelles S, Delmas Y, Sagnier S, Poli M, Olindo S, Renou P, Rouanet F, Sibon I.

J Stroke Cerebrovasc Dis. 2018 Nov;27(11):3163-3171. doi: 10.1016/j.jstrokecerebrovasdis.2018.07.017. Epub 2018 Sep 12. Review.

PMID:
30217637
12.

Trendelenburg Positioning in Large Vessel Ischaemic Stroke: A Pre-Post Observational Study Using Propensity Score Matching.

Gauthier A, Gérardin P, Renou P, Sagnier S, Debruxelles S, Poli M, Rouanet F, Olindo S, Sibon I.

Cerebrovasc Dis. 2018;46(1-2):24-32. doi: 10.1159/000490423. Epub 2018 Jul 27.

13.

Limbic encephalitis as a relapse of Whipple's disease with digestive involvement and spondylodiscitis.

Brönnimann D, Vareil MO, Sibon I, Lagier JC, Lepidi H, Puges M, Haneche F, Raoult D, Desclaux A, Neau D, Cazanave C.

Infection. 2019 Aug;47(4):637-641. doi: 10.1007/s15010-018-1173-x. Epub 2018 Jul 10.

PMID:
29987509
14.

Contribution of routine cardiac biological markers to the etiological workup of ischemic stroke.

Tomich C, Liegey JS, Sagnier S, Olindo S, Poli M, Debruxelles S, Rouanet F, Renou P, Sibon I.

Am J Emerg Med. 2019 Feb;37(2):194-198. doi: 10.1016/j.ajem.2018.05.010. Epub 2018 May 16.

PMID:
29804788
15.

Brain serotonin synthesis capacity in obsessive-compulsive disorder: effects of cognitive behavioral therapy and sertraline.

Lissemore JI, Sookman D, Gravel P, Berney A, Barsoum A, Diksic M, Nordahl TE, Pinard G, Sibon I, Cottraux J, Leyton M, Benkelfat C.

Transl Psychiatry. 2018 Apr 18;8(1):82. doi: 10.1038/s41398-018-0128-4.

16.

Influence of on-going treatment with angiotensin-converting enzyme inhibitor or angiotensin receptor blocker on the outcome of patients treated with intravenous rt-PA for ischemic stroke.

Gilliot S, Sibon I, Mas JL, Moulin T, Béjot Y, Cordonnier C, Giroud M, Odou P, Bordet R, Vivien D, Leys D; OPHELIE Investigators.

J Neurol. 2018 May;265(5):1166-1173. doi: 10.1007/s00415-018-8827-6. Epub 2018 Mar 16.

PMID:
29549467
17.

Controlled Education of patients after Stroke (CEOPS)- nurse-led multimodal and long-term interventional program involving a patient's caregiver to optimize secondary prevention of stroke: study protocol for a randomized controlled trial.

Mendyk AM, Duhamel A, Bejot Y, Leys D, Derex L, Dereeper O, Detante O, Garcia PY, Godefroy O, Montoro FM, Neau JP, Richard S, Rosolacci T, Sibon I, Sablot D, Timsit S, Zuber M, Cordonnier C, Bordet R; on the behalf of Strokavenir network.

Trials. 2018 Feb 22;19(1):137. doi: 10.1186/s13063-018-2483-0.

18.

Clinical Predictors of Stroke Mimics in Patients Treated with Recombinant Tissue Plasminogen Activator according to a Normal Multimodal Computed Tomography Imaging.

Olindo S, Chardonnet M, Renou P, Coignion C, Debruxelles S, Poli M, Sagnier S, Rouanet F, Sibon I.

J Stroke Cerebrovasc Dis. 2018 Feb;27(2):454-459. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.024. Epub 2017 Nov 8.

PMID:
29128327
19.

Head Positioning in Acute Stroke.

Sibon I, Gérardin P, Gauthier A.

N Engl J Med. 2017 Sep 14;377(11):1101. doi: 10.1056/NEJMc1709517. No abstract available.

PMID:
28905617
20.

Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.

Mas JL, Derumeaux G, Guillon B, Massardier E, Hosseini H, Mechtouff L, Arquizan C, Béjot Y, Vuillier F, Detante O, Guidoux C, Canaple S, Vaduva C, Dequatre-Ponchelle N, Sibon I, Garnier P, Ferrier A, Timsit S, Robinet-Borgomano E, Sablot D, Lacour JC, Zuber M, Favrole P, Pinel JF, Apoil M, Reiner P, Lefebvre C, Guérin P, Piot C, Rossi R, Dubois-Randé JL, Eicher JC, Meneveau N, Lusson JR, Bertrand B, Schleich JM, Godart F, Thambo JB, Leborgne L, Michel P, Pierard L, Turc G, Barthelet M, Charles-Nelson A, Weimar C, Moulin T, Juliard JM, Chatellier G; CLOSE Investigators.

N Engl J Med. 2017 Sep 14;377(11):1011-1021. doi: 10.1056/NEJMoa1705915.

21.

Medial thalamic stroke and its impact on familiarity and recollection.

Danet L, Pariente J, Eustache P, Raposo N, Sibon I, Albucher JF, Bonneville F, Péran P, Barbeau EJ.

Elife. 2017 Aug 24;6. pii: e28141. doi: 10.7554/eLife.28141.

22.

Resting Heart Rate Predicts Depression and Cognition Early after Ischemic Stroke: A Pilot Study.

Tessier A, Sibon I, Poli M, Audiffren M, Allard M, Pfeuty M.

J Stroke Cerebrovasc Dis. 2017 Oct;26(10):2435-2441. doi: 10.1016/j.jstrokecerebrovasdis.2017.05.040. Epub 2017 Jun 23.

PMID:
28652061
23.

Admission Brain Cortical Volume: An Independent Determinant of Poststroke Cognitive Vulnerability.

Sagnier S, Catheline G, Dilharreguy B, Munsch F, Bigourdan A, Poli M, Debruxelles S, Olindo S, Renou P, Rouanet F, Dousset V, Tourdias T, Sibon I.

Stroke. 2017 Aug;48(8):2113-2120. doi: 10.1161/STROKEAHA.117.017646. Epub 2017 Jun 16.

PMID:
28626050
24.

Transcranial Doppler to Detect Right to Left Communication: Evaluation Versus Transesophageal Echocardiography in Real Life.

Maillet A, Pavero A, Salaun P, Pibourdin A, Skopinski S, Thambo JB, Sibon I, Constans J, Boulon C.

Angiology. 2018 Jan;69(1):79-82. doi: 10.1177/0003319717712356. Epub 2017 Jun 6.

PMID:
28583003
25.

Gait Change Is Associated with Cognitive Outcome after an Acute Ischemic Stroke.

Sagnier S, Renou P, Olindo S, Debruxelles S, Poli M, Rouanet F, Munsch F, Tourdias T, Sibon I.

Front Aging Neurosci. 2017 May 18;9:153. doi: 10.3389/fnagi.2017.00153. eCollection 2017.

26.

Thalamic alterations remote to infarct appear as focal iron accumulation and impact clinical outcome.

Kuchcinski G, Munsch F, Lopes R, Bigourdan A, Su J, Sagnier S, Renou P, Pruvo JP, Rutt BK, Dousset V, Sibon I, Tourdias T.

Brain. 2017 Jul 1;140(7):1932-1946. doi: 10.1093/brain/awx114.

27.

High-dose acyclovir combined with foscavir (foscarnet) in the management of severe herpes simplex virus meningoencephalitis.

Sagnier S, Poli M, Debruxelles S, Renou P, Rouanet F, Sibon I.

Rev Neurol (Paris). 2017 Apr;173(4):240-242. doi: 10.1016/j.neurol.2017.03.006. Epub 2017 Mar 28. No abstract available.

PMID:
28363312
28.

Primary diffuse leptomeningeal gliomatosis: do we miss the diagnosis?

Lepreux S, Sagnier S, Perez JT, Léger F, Sibon I, Vital A.

Clin Neuropathol. 2017 Sep/Oct;36(5):222-226. doi: 10.5414/NP301018.

PMID:
28332472
29.

Patient and general practitioner perceptions of post-stroke difficulties may not always agree.

Babin N, Theux G, Sibon I, Dehail P, Prouteau A, Bélio C, Joseph PA, Aly F, Mazaux JM, Glize B.

Ann Phys Rehabil Med. 2017 Apr;60(2):117-119. doi: 10.1016/j.rehab.2017.01.003. Epub 2017 Feb 16. No abstract available.

30.

Percutaneous left atrial appendage closure followed by single antiplatelet therapy: Short- and mid-term outcomes.

Jalal Z, Dinet ML, Combes N, Pillois X, Renou P, Sibon I, Iriart X, Thambo JB.

Arch Cardiovasc Dis. 2017 Apr;110(4):242-249. doi: 10.1016/j.acvd.2016.09.006. Epub 2017 Jan 3.

31.

Left Atrial Appendage Closure in Patients with Atrial Fibrillation and Previous Intracerebral Hemorrhage.

Renou P, Thambo JB, Iriart X, Nicot S, Kabore N, Jalal Z, Olindo S, Debruxelles S, Poli M, Rouanet F, Sibon I.

J Stroke Cerebrovasc Dis. 2017 Mar;26(3):545-551. doi: 10.1016/j.jstrokecerebrovasdis.2016.11.126. Epub 2016 Dec 30.

PMID:
28041899
32.

Atrial fibrillation is a major cause of stroke in apneic patients: a prospective study.

Poli M, Philip P, Taillard J, Debruxelles S, Renou P, Orgogozo JM, Rouanet F, Sibon I.

Sleep Med. 2017 Feb;30:251-254. doi: 10.1016/j.sleep.2015.07.031. Epub 2016 Mar 4.

PMID:
28041720
33.

Stroke-Associated Pneumonia Risk Score: Validity in a French Stroke Unit.

Cugy E, Sibon I.

J Stroke Cerebrovasc Dis. 2017 Jan;26(1):225-229. doi: 10.1016/j.jstrokecerebrovasdis.2016.09.015. Epub 2016 Nov 7.

PMID:
27839768
34.

Proportion of single-chain recombinant tissue plasminogen activator and outcome after stroke.

Leys D, Hommet Y, Jacquet C, Moulin S, Sibon I, Mas JL, Moulin T, Giroud M, Sagnier S, Cordonnier C, Medeiros de Bustos E, Turc G, Ronzière T, Bejot Y, Detante O, Ouk T, Mendyk AM, Favrole P, Zuber M, Triquenot-Bagan A, Ozkul-Wermester O, Montoro FM, Lamy C, Faivre A, Lebouvier L, Potey C, Poli M, Hénon H, Renou P, Dequatre-Ponchelle N, Bodenant M, Debruxelles S, Rossi C, Bordet R, Vivien D; OPHELIE investigators and the STROKAVENIR network.

Neurology. 2016 Dec 6;87(23):2416-2426. Epub 2016 Nov 4.

PMID:
27815401
35.

The impact of intravenous thrombolysis on outcome of patients with acute ischemic stroke after 90 years old.

Sagnier S, Galli P, Poli M, Debruxelles S, Renou P, Olindo S, Rouanet F, Sibon I.

BMC Geriatr. 2016 Aug 25;16:156. doi: 10.1186/s12877-016-0331-1.

36.

Affective Prosody and Depression After Stroke: A Pilot Study.

Villain M, Cosin C, Glize B, Berthoz S, Swendsen J, Sibon I, Mayo W.

Stroke. 2016 Sep;47(9):2397-400. doi: 10.1161/STROKEAHA.116.013852. Epub 2016 Aug 9.

PMID:
27507865
37.

Language features in the acute phase of poststroke severe aphasia could predict the outcome.

Glize B, Villain M, Richert L, Vellay M, de Gabory I, Mazaux JM, Dehail P, Sibon I, Laganaro M, Joseph PA.

Eur J Phys Rehabil Med. 2017 Apr;53(2):249-255. doi: 10.23736/S1973-9087.16.04255-6. Epub 2016 Jul 14.

38.

Extending percutaneous left atrial appendage closure indications using the AMPLATZER™ Cardiac Plug device in patients with persistent left atrial appendage thrombus: The thrombus trapping technique.

Jalal Z, Iriart X, Dinet ML, Selly JB, Tafer N, Renou P, Sibon I, Thambo JB.

Arch Cardiovasc Dis. 2016 Dec;109(12):659-666. doi: 10.1016/j.acvd.2016.02.012. Epub 2016 Jul 8.

39.

Changes in Activated Thrombin-Activatable Fibrinolysis Inhibitor Levels Following Thrombolytic Therapy in Ischemic Stroke Patients Correlate with Clinical Outcome.

Alessi MC, Gaudin C, Grosjean P, Martin V, Timsit S, Mahagne MH, Larrue V, Sibon I, Zuber M, Brouns R, Montaner J, Castellanos M, Donazzolo Y, Cho TH, Suissa L, Mechtouff L, Derex L, Suchon P, Mezzapesa A, Nighoghossian N.

Cerebrovasc Dis. 2016;42(5-6):404-414. Epub 2016 Jul 8.

PMID:
27387478
40.

Impact of thrombolysis in acute ischaemic stroke without occlusion: an observational comparative study.

Ajili N, Decroix JP, Preda C, Labreuche J, Lopez D, Bejot Y, Michel P, Sévin-Allouet M, Sibon I, Vergnet S, Wang A, Sanda N, Mazighi M, Bourdain F, Lapergue B.

Eur J Neurol. 2016 Aug;23(8):1380-6. doi: 10.1111/ene.13042. Epub 2016 May 24.

PMID:
27222165
41.

Thalamic amnesia after infarct: The role of the mammillothalamic tract and mediodorsal nucleus.

Pergola G, Danet L, Barbeau EJ, Eustache P, Planton M, Raposo N, Sibon I, Albucher JF, Bonneville F, Peran P, Pariente J.

Neurology. 2016 May 17;86(20):1928. doi: 10.1212/WNL.0000000000002730. No abstract available.

PMID:
27185898
42.

[Post-stroke depression: frequent and early screening].

Sibon I.

Rev Prat. 2016 Apr;66(4):451-452. French. No abstract available.

PMID:
30512714
43.

Post-acute referral of stroke victims in a French urban area: Results of a specific program.

Cassoudesalle H, Nozères A, Petit H, Cressot V, Muller F, Rouanet F, Sibon I, Joseph PA, Dehail P.

Ann Phys Rehabil Med. 2016 Sep;59(4):248-54. doi: 10.1016/j.rehab.2016.02.003. Epub 2016 Mar 19.

44.

Erdheim-Chester Disease: An Unusual Cause of Intracranial Vasculitis and Progressive Leukoencephalopathy.

Sagnier S, Debruxelles S, Lepreux S, Sibon I.

J Stroke Cerebrovasc Dis. 2016 May;25(5):e63-e65. doi: 10.1016/j.jstrokecerebrovasdis.2016.01.042. Epub 2016 Mar 17.

PMID:
26996751
45.

Early Fiber Number Ratio Is a Surrogate of Corticospinal Tract Integrity and Predicts Motor Recovery After Stroke.

Bigourdan A, Munsch F, Coupé P, Guttmann CR, Sagnier S, Renou P, Debruxelles S, Poli M, Dousset V, Sibon I, Tourdias T.

Stroke. 2016 Apr;47(4):1053-9. doi: 10.1161/STROKEAHA.115.011576. Epub 2016 Mar 15.

PMID:
26979863
46.

Dopamine cross-sensitization between psychostimulant drugs and stress in healthy male volunteers.

Booij L, Welfeld K, Leyton M, Dagher A, Boileau I, Sibon I, Baker GB, Diksic M, Soucy JP, Pruessner JC, Cawley-Fiset E, Casey KF, Benkelfat C.

Transl Psychiatry. 2016 Feb 23;6:e740. doi: 10.1038/tp.2016.6.

47.

Very early social support following mild stroke is associated with emotional and behavioral outcomes three months later.

Villain M, Sibon I, Renou P, Poli M, Swendsen J.

Clin Rehabil. 2017 Jan;31(1):135-141. doi: 10.1177/0269215515623600. Epub 2016 Jul 10.

PMID:
26851250
48.

Cerebral changes and cognitive impairment after an ischemic heart disease: a multimodal MRI study.

Bernard C, Catheline G, Dilharreguy B, Couffinhal T, Ledure S, Lassalle-Lagadec S, Callaert D, Allard M, Sibon I.

Brain Imaging Behav. 2016 Sep;10(3):893-900. doi: 10.1007/s11682-015-9483-4.

PMID:
26589710
49.

Stroke Location Is an Independent Predictor of Cognitive Outcome.

Munsch F, Sagnier S, Asselineau J, Bigourdan A, Guttmann CR, Debruxelles S, Poli M, Renou P, Perez P, Dousset V, Sibon I, Tourdias T.

Stroke. 2016 Jan;47(1):66-73. doi: 10.1161/STROKEAHA.115.011242. Epub 2015 Nov 19.

PMID:
26585396
50.

Thalamic amnesia after infarct: The role of the mammillothalamic tract and mediodorsal nucleus.

Danet L, Barbeau EJ, Eustache P, Planton M, Raposo N, Sibon I, Albucher JF, Bonneville F, Peran P, Pariente J.

Neurology. 2015 Dec 15;85(24):2107-15. doi: 10.1212/WNL.0000000000002226. Epub 2015 Nov 13.

Supplemental Content

Support Center